Open-label Study of Accelerated Low-Frequency TMS for Treatment-Resistant Depression in People With Epilepsy.

Providing evidence-based psychiatric care and advanced TMS therapy for adults experiencing depression, anxiety, and treatment-resistant mood disorders.